Anti-Arrhythmia Agents

"Anti-Arrhythmia Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.

Descriptor ID	D000889
MeSH Number(s)	D27.505.954.411.097
Concept/Terms	Anti-Arrhythmia Agents Anti-Arrhythmia Agents Agents, Anti-Arrhythmia Anti Arrhythmia Agents Antiarrhythmic Drugs Drugs, Antiarrhythmic Antiarrhythmia Agents Agents, Antiarrhythmia Antiarrhythmia Drugs Drugs, Antiarrhythmia Anti-Arrhythmia Drugs Anti Arrhythmia Drugs Drugs, Anti-Arrhythmia Anti-Arrhythmics Anti Arrhythmics Cardiac Depressants Cardiac Depressants Depressants, Cardiac Myocardial Depressants Depressants, Myocardial Antifibrillatory Agents Antifibrillatory Agents Agents, Antifibrillatory

Below are MeSH descriptors whose meaning is more general than "Anti-Arrhythmia Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Cardiovascular Agents [D27.505.954.411]
Anti-Arrhythmia Agents [D27.505.954.411.097]

Below are MeSH descriptors whose meaning is related to "Anti-Arrhythmia Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-Arrhythmia Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-Arrhythmia Agents" by people in this website by year, and whether "Anti-Arrhythmia Agents" was a major or minor topic of these publications.

Bar chart showing 228 publications over 24 distinct years, with a maximum of 20 publications in 2009 and 2010 and 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	0	1
1998	1	0	1
2002	1	1	2
2003	5	3	8
2004	8	3	11
2005	13	4	17
2006	4	3	7
2007	8	2	10
2008	9	6	15
2009	15	5	20
2010	10	10	20
2011	13	7	20
2012	6	6	12
2013	3	6	9
2014	5	6	11
2015	6	2	8
2016	11	5	16
2017	3	1	4
2018	3	4	7
2019	5	3	8
2020	6	3	9
2021	0	1	1
2022	0	10	10
2023	1	0	1

Below are the most recent publications written about "Anti-Arrhythmia Agents" by people in Profiles.

Reiffel JA, Blomstr?m-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Camm AJ. Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey. Europace. 2023 Jun 02; 25(6).

View in: PubMed
Naccarelli GV, Kowey PR. Should we limit antiarrhythmic drug choice in patients with left ventricular hypertrophy? J Cardiovasc Electrophysiol. 2023 Feb; 34(2):453-454.

View in: PubMed
McGee MJ, Ray M, Brienesse SC, Sritharan S, Boyle AJ, Jackson N, Leitch JW, Sverdlov AL. Remote monitoring in patients with heart failure with cardiac implantable electronic devices: a systematic review and meta-analysis. Open Heart. 2022 11; 9(2).

View in: PubMed
Burashnikov A. Atrial Fibrillation Induced by Anticancer Drugs and Underling Mechanisms. J Cardiovasc Pharmacol. 2022 10 01; 80(4):540-546.

View in: PubMed
Sahai SK, Balonov K, Bentov N, Bierle DMM, Browning LM, Cummings KC, Dougan BM, Maxwell M, Merli GJ, Oprea AD, Sweitzer B, Mauck KF, Urman RD. Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement. Mayo Clin Proc. 2022 09; 97(9):1734-1751.

View in: PubMed
Handelsman Y, Bunch TJ, Rodbard HW, Steinberg BA, Thind M, Bigot G, Konigsberg L, Wieloch M, Kowey PR. Impact of dronedarone on patients with atrial fibrillation and diabetes: A sub-analysis of the ATHENA and EURIDIS/ADONIS studies. J Diabetes Complications. 2022 07; 36(7):108227.

View in: PubMed
Mar PL, Horbal P, Chung MK, Dukes JW, Ezekowitz M, Lakkireddy D, Lip GYH, Miletello M, Noseworthy PA, Reiffel JA, Tisdale JE, Olshansky B, Gopinathannair R. Drug Interactions Affecting Antiarrhythmic Drug Use. Circ Arrhythm Electrophysiol. 2022 05; 15(5):e007955.

View in: PubMed
Camm AJ, Blomstr?m-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Reiffel JA. AIM-AF: A Physician Survey in the United States and Europe. J Am Heart Assoc. 2022 03 15; 11(6):e023838.

View in: PubMed
Crijns HJGM, Elvan A, Al-Windy N, Tuininga YS, Badings E, Aksoy I, Van Gelder IC, Madhavapeddi P, Camm AJ, Kowey PR, Ruskin JN, Belardinelli L. Open-Label, Multicenter Study of Flecainide Acetate Oral Inhalation Solution for Acute Conversion of Recent-Onset, Symptomatic Atrial Fibrillation to Sinus Rhythm. Circ Arrhythm Electrophysiol. 2022 03; 15(3):e010204.

View in: PubMed
Thind M, McKindley DS, Reiffel JA, Naccarelli GV, Stewart J, Kowey PR. Predictors of dronedarone plasma drug concentrations and effect on atrial fibrillation/atrial flutter recurrence: Analyses from the EURIDIS and ADONIS studies. Clin Cardiol. 2022 Jan; 45(1):119-128.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement